Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Environmental Health Biostatistician Whose Work Has Impacted Air Pollution Regulation Joins Harvard School Of Public Health
Francesca Dominici, PhD, a biostatistican whose work has affected air pollution regulation, has joined the faculty of the Harvard School of Public Health (HSPH) as professor of biostatistics.

Lawsuit Filed Over Gene Patent
A group of cancer patients, genetic researchers and professional pathologist organizations has filed a lawsuit against Myriad Genetics and the U.S. Patent Office over the patent of two genes associated with an increased risk of breast and ovarian cancers, the New York Times reports. According to the Times, the government more than 10 years ago granted Myriad the patent on the BRCA1 and BRCA2 genes, as well as the company"s genetic test that measures a patient"s risk for the cancers.The lawsuit was filed by the American Civil Liberties Union and is believed to be the first of its kind, the Times reports. The lawsuit challenges the decision to grant patents on genes to Myriad and companies like it. The plaintiffs say that patents on genes restrict medical and research efforts, while companies like Myriad have said that the patent system supports innovation by giving them a temporary monopoly after they make a discovery, thereby rewarding prior investment in research and development.Wendy Chung, the director of clinical genetics at Columbia University and a plaintiff in the case, said, "With a sole provider, there"s mediocrity." The plaintiffs say that BRCA testing would improve with market competition. Furthermore, some plaintiffs argue that certain natural materials cannot be patented. Jan Nowak, president of the Association for Molecular Pathology and a plaintiff in the case, said, "You can"t patent my DNA, any more than you can patent my right arm, or patent my blood."To date, two government panels, including the National Research Council, found no evidence that gene patents result in significant impediments to research or medical care (Schwartz, New York Times, 5/13).
News of the day
Statement By HANYS' President Daniel Sisto Regarding The State Department Of Health Hospital-Acquired Infection Report
"Patients, policymakers, and practitioners all agree that reliable, accurate, and consistent quality measures are essential elements in improving health care services. This report is a clear indication that the efforts hospitals continue to make to prevent and control infections are having a positive impact on patient care. Hospitals are actively developing and sharing infection control techniques and best practices, and have engrained in their organizations a zero tolerance policy for preventable patient harm.
Health Insurance

Atrial Fibrillation Linked To Increased Hospitalization In Heart Failure Patients

Patients with atrial fibrillation, common in those with advanced chronic heart failure, have an increased risk of hospitalization due to heart failure, according to new research from researchers at the University of Alabama at Birmingham (UAB). The findings, published in June in the European Heart Journal, also suggest that atrial fibrillation is not associated with an increased risk of death in heart failure patients, contradicting previous assumptions. "Our findings show that the presence of atrial fibrillation in heart failure patients did not increase their risk of death, as has been previously suggested, but did increase the risk of hospitalization due to worsening heart failure," said Mustafa Ahmed, M.D., a physician-scientist at the UAB American Board of Internal Medicine Research Pathway Program and the study"s lead investigator. Atrial fibrillation is a condition with irregular heart rhythm and is often accompanied by increased heart rate. "Importantly, atrial fibrillation significantly increased hospitalization due to heart failure only in patients not receiving a beta-blocker or drugs that block the beta-receptors in the heart but not in those receiving a beta-blocker," said Ali Ahmed, M.D., MPH, associate professor in the division of gerontology, geriatrics and palliative care medicine, director of UAB"s Geriatric Heart Failure Clinic and the study"s senior investigator. "In patients with heart failure and atrial fibrillation, beta-blockers, which help reduce heart rate, may be useful in reducing the risk of hospitalization due to worsening heart failure." Ahmed and colleagues matched 487 pairs of heart failure patients with and without atrial fibrillation from the Beta-Blocker Evaluation of Survival Trial. All-cause mortality occurred in 38 percent of the patients with atrial fibrillation against 37 percent of patients without. However, 44 percent patients with atrial fibrillation were hospitalized for worsening heart failure over the course of the trial, against only 38 percent without. The research was supported through a grant from the National Heart, Lung and Blood Institute, one of the National Institutes of Health, and a generous gift from Ms. Jean B. Morris of Birmingham, Alabama. Ahmed"s co-researchers were Mustafa Ahmed, M.D., James Ekundayo, M.D., DrPH, Inmaculada Aban, Ph.D., Bo Liu, MB, MPH, all from UAB; Michel White, MD, Montreal Heart Institute; Thomas Love, Ph.D., Case Western Reserve University; and Wilbert Aronow, MD, New York Medical College. About UAB Health System The UAB Health System includes all of the University of Alabama at Birmingham"s patient care activities, including UAB Hospital, the Callahan Eye Foundation Hospital and The Kirklin Clinic. UAB is the state of Alabama"s largest employer and an internationally renowned research university and academic health center whose professional schools and specialty patient care programs are consistently ranked as among the nation"s top 50. University of Alabama at Birmingham


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009